Registration Header
REGISTER TODAY!

SAB Virtual R&D Event

Start Date:10/13/2021

Start Time:10:00 AM EDT

Duration:120 minutes

Abstract:

Introduction to SAB’s Unique DiversitAb™ Immunotherapy Platform

If you're already registered for the SAB Virtual R&D Event webcast, click below:

ALREADY REGISTERED?

Speakers

Eddie Sullivan, PhD

SAB Biotherapeutics

Co-Founder, President & CEO

Arturo Casadevall, M.D., Ph.D.

Johns Hopkins Bloomberg School of Public Health Johns Hopkins School of Medicine

The Alfred and Jill Sommer Professor and Chair W. Harry Feinstone Dept of Molecular Microbiology & Immunology Bloomberg Distinguished Professor

Tom Luke, MD

SAB Biotherapeutics

Chief Medical Officer

Christoph Bausch, PhD

SAB Biotherapeutics

Chief Science Officer

Michael J. Haller, MD, MS-CI

University of Florida College of Medicine

Professor and Chief Silverstein Family Eminent Scholar Pediatric Endocrinology
First Name
Last Name
Email Address
Company
Job Title
Phone